Sickle cell disease: open trials in Saudi Arabia

6 open trials have a site in Saudi Arabia. Registry data; only the trial team decides who can take part.

NCT06975865
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Trial Treatment · Phase 3 · Sanofi
Riyadh
Registry updated 2026-10-15
NCT06609226
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Trial Treatment · Phase 3 · Novo Nordisk A/S
Prince Mohammad Bin Naser Hospital, Jizan · King Khalid University Hospital, Riyadh
Registry updated 2026-09-18
NCT06612268
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Trial Treatment · Phase 3 · Novo Nordisk A/S
Al-Moosa Health Group, Al Ahsa · King Abdulaziz Hospital-Al Ahsa-National Guard, Al Ahsa · Prince Mohammed bin Fahad Hospital for Blood Disorders, Al Qaţīf · National Guard Hospital Dammam, Dhahran · King Faisal Specialist Hospital & Research Centre Riyadh, Riyadh · King Khalid University Hospital, Riyadh
Registry updated 2026-09-17
NCT05431088
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Trial Treatment · Phase 2/3 · Pfizer
King Khalid University Hospital, Riyadh
Registry updated 2026-08-18
NCT05477563
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
Trial Treatment · Phase 3 · Vertex Pharmaceuticals Incorporated
King Faisal Specialist Hospital & Research Centre - Riyadh - Hematology, Al Mathar Ash Shamali
Registry updated 2026-03-23
NCT07188766
Efficacy of Liberal Versus Restricted IV Fluid Approach in the Management of Sickle Cell Vaso-Occlusive Crisis
Trial Treatment · Imam Abdulrahman Bin Faisal University
King Fahd Hospital of the University, Dammam · King Saud University Medical City, Riyadh
Registry updated 2026-03-18

All Sickle cell disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error

Sickle cell disease: open trials in Saudi Arabia

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

Efficacy of Liberal Versus Restricted IV Fluid Approach in the Management of Sickle Cell Vaso-Occlusive Crisis